| Net Cash Provided by (Used in) Operating Activities |
$1,589,396 |
USD |
-103% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$750,000 |
USD |
58% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$305,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
225,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
3,056,822 |
shares |
458% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$1,600,000 |
USD |
-100% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$38,777,166 |
USD |
9890% |
Q3 2025 |
Q3 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$6,259,191 |
USD |
53% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
45,044 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
15,000,000 |
shares |
|
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
$279,105 |
USD |
|
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$131,809,991 |
USD |
9.8% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
45,044 |
shares |
|
Q3 2025 |
Q3 2025 |
| Share-based Payment Arrangement, Expense |
$128,059 |
USD |
-88% |
Q4 2024 |
FY 2024 |
| Interest Expense |
$74,000 |
USD |
8.8% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2025 |
Q3 2025 |